The Tabacalera Civic Centre will host the CIRCE Cantabria Conference, “Preventing Frailty from Primary and Community Care: Lessons Learned and Future Challenges”, a meeting that will bring together healthcare professionals, institutions, patients, and community agents with the aim of sharing results, experiences, and challenges in the prevention of frailty among older adults. The event, which […]
The Valdecilla Health Research Institute (IDIVAL) has released the draft of the calls under the Health Cluster of the Horizon Europe Programme 2026–2027, which are expected to open in mid-February. The information presents a wide range of funding opportunities for health research and innovation projects, structured by deadline, submission format (single-stage or two-stage), and type […]
IDIVAL researchers clarify the role of the NF‑κB pathway in this inflammatory disease The research team focused on characterizing Immunoglobulin A–mediated vasculitis from the Immunopathology Group at the Marqués de Valdecilla Research Institute (IDIVAL) has demonstrated that two genes involved in the immune response, NFKB1 and NFKBIA, do not influence the risk of developing this […]
On Thursday, 29 January, the next session of the Santander Biomedical Lectures programme will take place. On this occasion, Pilar Pinilla will deliver a lecture entitled: “Decision‑making on medicine pricing and reimbursement: value frameworks, elements, and structured decision‑making” Pilar Pinilla holds a degree in Business Administration and Management from the University of La Laguna, and […]
A multidisciplinary team from the Valdecilla Health Research Institute (IDIVAL), the Marqués de Valdecilla University Hospital (HUMV), and the Valdecilla Virtual Hospital has validated, in an animal model, a new dynamic traction device, Dynatract®, designed to improve the treatment of “Open Abdomen,” a severe complication that arises after complex surgeries or severe infections. These patients […]
Dr. Álvaro Díaz-González, attending physician in the Digestive Diseases Department at Marqués de Valdecilla University Hospital and researcher in the Clinical and Translational Research Group on Digestive Diseases at the Valdecilla Research Institute (IDIVAL), is the first author of the new “Clinical Practice Guidelines for the Diagnosis and Treatment of Cholestatic Liver Diseases in Adult […]
The Marqués de Valdecilla Research Institute (IDIVAL), the Cantabrian Health Service (SCS), and Gilead Sciences S.L.U. have formalised a new collaboration agreement aimed at strengthening research, training, and health promotion in the field of viral hepatitis diagnosis in Cantabria. The agreement is framed within Project FOCUS, an international initiative focused on improving screening and linkage […]
Mental health has become one of the major healthcare priorities in Europe, and cooperation between territories is key to making effective and equitable progress. In this context, the Marqués de Valdecilla Health Research Institute (IDIVAL) plays a relevant role in the Joint Action PRISM (JA PRISM), an ambitious European project that brings together 59 organisations […]
The advisory body met to assess scientific progress, human resources and strategic planning The IDIVAL’s External Scientific Advisory Board reviews 2025 activity and the Institute’s main strategic priorities of the Marqués de Valdecilla Health Research Institute (IDIVAL) met at the Marqués de Valdecilla University Hospital to review the activity carried out by the Institute throughout […]
The session focused on alignment with European standards in science, management, and research talent The Valdecilla Health Research Institute (IDIVAL) held an institutional session within the framework of the Santander Biomedical Lectures entitled “HRS4R at IDIVAL: Science, Management and Talent for the European Future”, during which it presented to the research community the update of […]
